A Translational Perspective of a Deubiquitinase Inhibitor in Antitumor Immunity.
作者信息
Li Yangyang, Li Bin
机构信息
Key Laboratory of Molecular Virology and Immunology, CAS Center for Excellence in Molecular Cell Science, Unit of Molecular Immunology, Institut Pasteur of Shanghai, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200025, China.
Key Laboratory of Molecular Virology and Immunology, CAS Center for Excellence in Molecular Cell Science, Unit of Molecular Immunology, Institut Pasteur of Shanghai, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200025, China; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
出版信息
EBioMedicine. 2016 Nov;13:7-8. doi: 10.1016/j.ebiom.2016.11.008. Epub 2016 Nov 8.
Abstract
摘要
相似文献
1
A Translational Perspective of a Deubiquitinase Inhibitor in Antitumor Immunity.
EBioMedicine. 2016 Nov;13:7-8. doi: 10.1016/j.ebiom.2016.11.008. Epub 2016 Nov 8.
2
Translating Pembrolizumab to Clinical Practice: Speak Immunology and Learn Fast!
Clin Cancer Res. 2015 Oct 1;21(19):4251-3. doi: 10.1158/1078-0432.CCR-15-1126. Epub 2015 Jul 13.
3
LIGHT May Improve Immune Checkpoint Blockade Response.
Cancer Discov. 2016 Jun;6(6):OF9. doi: 10.1158/2159-8290.CD-NB2016-042. Epub 2016 Apr 14.
4
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition.
Clin Cancer Res. 2016 Apr 15;22(8):1865-74. doi: 10.1158/1078-0432.CCR-15-1507.
5
Tumor and T-cell metabolism: new insights into melanoma therapy.
Clin Adv Hematol Oncol. 2016 Apr;14(4):232-4.
6
Chemokines and cancer: new immune checkpoints for cancer therapy.
Curr Opin Immunol. 2018 Apr;51:140-145. doi: 10.1016/j.coi.2018.03.004. Epub 2018 Mar 24.
7
Immune Checkpoint Therapy in Melanoma.
Cancer J. 2016 Mar-Apr;22(2):73-80. doi: 10.1097/PPO.0000000000000183.
8
Immune Checkpoint Therapies in Prostate Cancer.
Cancer J. 2016 Mar-Apr;22(2):117-20. doi: 10.1097/PPO.0000000000000176.
9
Immune Checkpoint Therapy in Head and Neck Cancers.
Cancer J. 2016 Mar-Apr;22(2):108-16. doi: 10.1097/PPO.0000000000000180.
10
Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control.
Cancer J. 2016 Mar-Apr;22(2):130-7. doi: 10.1097/PPO.0000000000000181.
引用本文的文献
1
Gallic acid induces T-helper-1-like T cells and strengthens immune checkpoint blockade efficacy.
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2021-004037.
本文引用的文献
1
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor Immunity.
EBioMedicine. 2016 Nov;13:99-112. doi: 10.1016/j.ebiom.2016.10.018. Epub 2016 Oct 15.
2
Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60.
Cell Rep. 2014 Jun 12;7(5):1471-1480. doi: 10.1016/j.celrep.2014.04.021. Epub 2014 May 15.
3
Regulatory T cells in cancer immunotherapy.
Curr Opin Immunol. 2014 Apr;27:1-7. doi: 10.1016/j.coi.2013.12.005. Epub 2014 Jan 14.
4
The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3.
Immunity. 2013 Aug 22;39(2):272-85. doi: 10.1016/j.immuni.2013.08.006.
5
Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity.
Immunity. 2013 Aug 22;39(2):259-71. doi: 10.1016/j.immuni.2013.05.018.
6
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.
Cancer Cell. 2012 Sep 11;22(3):345-58. doi: 10.1016/j.ccr.2012.08.007.
7
The blockade of immune checkpoints in cancer immunotherapy.
Nat Rev Cancer. 2012 Mar 22;12(4):252-64. doi: 10.1038/nrc3239.
8
The multifaceted roles of USP7: new therapeutic opportunities.
Cell Biochem Biophys. 2011 Jun;60(1-2):61-8. doi: 10.1007/s12013-011-9185-5.
9
FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4571-6. doi: 10.1073/pnas.0700298104. Epub 2007 Mar 7.
10
Regulatory T cell lineage specification by the forkhead transcription factor foxp3.
Immunity. 2005 Mar;22(3):329-41. doi: 10.1016/j.immuni.2005.01.016.
Zotero 插件